Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.48 HKD | +1.80% | +0.47% | +8.03% |
Mar. 28 | Aim Vaccine Submits Pre-Applications for Clinical Trials for Two Vaccines; Shares Up 3% | MT |
Mar. 28 | Aim Vaccine's Loss Quadruples in 2023 as Revenue Slips 6%; Shares Up 3% | MT |
Sales 2024 * | 3.41B 471M 3.69B | Sales 2025 * | 4.67B 647M 5.05B | Capitalization | 9.31B 1.29B 10.07B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3 x |
Net Debt 2024 * | 904M 125M 978M | Net Debt 2025 * | 575M 79.58M 622M | EV / Sales 2025 * | 2.12 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,624 |
Yield 2024 * |
1.65% | Yield 2025 * |
3.14% | Free-Float | 22.09% |
1 day | +1.80% | ||
1 week | -2.75% | ||
Current month | +0.47% | ||
1 month | -1.97% | ||
3 months | +29.66% | ||
6 months | -4.61% | ||
Current year | +8.03% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Wen Guan
PSD | President | 57 | 16-11-30 |
Li Xin Niu
DFI | Director of Finance/CFO | 52 | 15-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ker Wei Pei
BRD | Director/Board Member | 67 | 20-09-18 |
Xin Zhou
BRD | Director/Board Member | 55 | 13-04-30 |
Yan Zhou
CEO | Chief Executive Officer | 58 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 8.48 | +1.80% | 219 800 |
24-05-07 | 8.33 | -2.57% | 258,400 |
24-05-06 | 8.55 | -3.72% | 236,000 |
24-05-03 | 8.88 | +1.83% | 800 |
24-05-02 | 8.72 | +3.32% | 143,200 |
Delayed Quote Hong Kong S.E., May 08, 2024 at 04:08 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.03% | 1.29B | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+53.42% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+6.22% | 8.83B |
- Stock Market
- Equities
- 6660 Stock